Despite the potential for increased androgen-mediated neuroprotection and repressed menstrual-related hormonal fluctuations to reduce migraine susceptibility, the imbalance of hormonal signaling might still induce headache via elevated estrogen and prolactin. The gene discussed is PRL; the disease is migraine disorder.